The Hydration Pharmaceuticals Co (ASX:HPC) ROCE % : -338.93% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is The Hydration Pharmaceuticals Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. The Hydration Pharmaceuticals Co's annualized ROCE % for the quarter that ended in Dec. 2023 was -338.93%.

The Hydration Pharmaceuticals Co ROCE % Historical Data

The historical data trend for The Hydration Pharmaceuticals Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Hydration Pharmaceuticals Co ROCE % Chart

The Hydration Pharmaceuticals Co Annual Data

Trend

Dec21

Dec22

Dec23

ROCE %

-45.94

-104.07

-133.09

The Hydration Pharmaceuticals Co Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	-	-59.17	-216.64	-81.55	-338.93

The Hydration Pharmaceuticals Co ROCE % Calculation

The Hydration Pharmaceuticals Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-11.144	/	( ( (15.399 - 3.966)	+	(9.996 - 4.682) )	/ 2 )
	=	-11.144	/	( (11.433	+	5.314)	/ 2 )
	=	-11.144	/	8.3735
	=	-133.09 %

The Hydration Pharmaceuticals Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-15.94	/	( ( (7.313 - 3.221)	+	(9.996 - 4.682) )	/ 2 )
	=	-15.94	/	( ( 4.092	+	5.314 )	/ 2 )
	=	-15.94	/	4.703
	=	-338.93 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

The Hydration Pharmaceuticals Co (ASX:HPC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

The Hydration Pharmaceuticals Co ROCE % Related Terms

Thank you for viewing the detailed overview of The Hydration Pharmaceuticals Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

The Hydration Pharmaceuticals Co (ASX:HPC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » The Hydration Pharmaceuticals Co Ltd (ASX:HPC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121

Website

https://www.hydralyte.com

The Hydration Pharmaceuticals Co Ltd is engaged in the marketing and sale of liquid, tablet and powder hydration solution products into the North American markets of Canada and the United States. Some of its products include Hydration + Immune System Boost, Effervescent Electrolyte Tablets, Oral Rehydration Solution, and Immunity Booster Bundle.

The Hydration Pharmaceuticals Co (ASX:HPC) Headlines

No Headlines